131 related articles for article (PubMed ID: 30297572)
21. Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
Jiang C; Zhang Y; Yu HF; Yu XT; Zhou SJ; Tan YF
Tumour Biol; 2012 Dec; 33(6):2167-72. PubMed ID: 22941466
[TBL] [Abstract][Full Text] [Related]
22. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of livin protein in hepatocellular carcinoma.
Guo H; Gao YT; Zhang Q; Jing L; Liu T; Shi WX; Zhai DK; Jing X; Du Z
Dis Markers; 2013; 35(5):489-96. PubMed ID: 24223461
[TBL] [Abstract][Full Text] [Related]
24. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
25. Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.
Cui Z; Yu X; Guo L; Wei Y; Zheng S; Li W; Chen P; Zhu J; Peng J
Dis Markers; 2013; 35(6):915-23. PubMed ID: 24427779
[TBL] [Abstract][Full Text] [Related]
26. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
Trerotoli P; Fransvea E; Angelotti U; Antonaci G; Lupo L; Mazzocca A; Mangia A; Antonaci S; Giannelli G
Mol Cancer; 2009 May; 8():29. PubMed ID: 19473531
[TBL] [Abstract][Full Text] [Related]
27. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract][Full Text] [Related]
28. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
[TBL] [Abstract][Full Text] [Related]
29. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
[TBL] [Abstract][Full Text] [Related]
30. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis.
Tsuzurahara S; Sata M; Iwamoto O; Shichijo S; Kojiro M; Tanikawa K; Itoh K
Jpn J Cancer Res; 1997 Sep; 88(9):915-8. PubMed ID: 9369941
[TBL] [Abstract][Full Text] [Related]
31. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Value of Serum SMP30 and Anti-SMP30 Antibody in Hepatocellular Carcinoma.
Zheng SX; Xiang BD; Long JM; Qu C; Mo ZJ; Li K; Zhuang Y; Lv ZL; Zhou SF
Lab Med; 2018 Jul; 49(3):203-210. PubMed ID: 29562243
[TBL] [Abstract][Full Text] [Related]
33. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
[TBL] [Abstract][Full Text] [Related]
34. Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.
Heo CK; Hwang HM; Lee HJ; Kwak SS; Yoo JS; Yu DY; Lim KJ; Lee S; Cho EW
Sci Rep; 2019 Jul; 9(1):11059. PubMed ID: 31363116
[TBL] [Abstract][Full Text] [Related]
35. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
37. Expression of GAGE family proteins in malignant melanoma.
Bazhin AV; Wiedemann N; Schnölzer M; Schadendorf D; Eichmüller SB
Cancer Lett; 2007 Jun; 251(2):258-67. PubMed ID: 17194529
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues.
Yang XA; Dong XY; Qiao H; Wang YD; Peng JR; Li Y; Pang XW; Tian C; Chen WF
Lab Invest; 2005 Feb; 85(2):205-13. PubMed ID: 15580283
[TBL] [Abstract][Full Text] [Related]
39. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
40. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
